Insider Trading History of Hollingsworth Jane H

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Hollingsworth Jane H since 2011. This trader's CIK number is 1297141. At the time of last reporting, Hollingsworth Jane H was the Director of Cervomed Inc.. (stock ticker symbol CRVO). Also see all insider trading activities at Cervomed Inc..

Note that in the past Hollingsworth Jane H also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Nupathe Inc. (PATH) by Hollingsworth Jane H

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2011 PATH 20,000 $51,280 0 $0 0 $0

Yearly summary of insider trading at Cervomed Inc. (CRVO) by Hollingsworth Jane H

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 CRVO 0 $0 0 $0 671 $0
2022 CRVO 0 $0 0 $0 732 $0
2021 CRVO 32,786 $19,999 0 $0 0 $0


Insider trading activities at 2 companies by Hollingsworth Jane H:

1. Nupathe Inc. (PATH)

2. Cervomed Inc. (CRVO)

Table 1. Insider trading of Nupathe Inc. (PATH) by Hollingsworth Jane H

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2011-09-09 PATH Buy 20,000 2.56 51,280

Table 2. Insider trading of Cervomed Inc. (CRVO) by Hollingsworth Jane H

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-08-31 CRVO Option Ex 122 .00 0
2023-05-31 DFFN Option Ex 183 .00 0
2023-05-31 DFFN Option Ex 183 .00 0
2023-02-28 DFFN Option Ex 183 .00 0
2022-11-30 DFFN Option Ex 183 .00 0
2022-11-30 DFFN Option Ex 183 .00 0
2022-08-31 DFFN Option Ex 183 .00 0
2022-05-31 DFFN Option Ex 183 .00 0
2021-05-13 DFFN Buy 32,786 .61 19,999

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hollingsworth Jane H (Director of Cervomed Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.